EMEA-000511-PIP01-08-M04

Key facts

Invented name
Hemangiol
Active substance
propranolol hydrochloride
Therapeutic area
Dermatology
Decision number
P/0004/2013
PIP number
EMEA-000511-PIP01-08-M04
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of haemangioma
Route(s) of administration
Oral use
Contact for public enquiries
Pierre Fabre Dermatologie
E-mail: peggy.michel@pierre-fabre.com
Country: France
Tel. +33 534506450
Fax +33 149100216
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000511-PIP01-08-M04
Compliance opinion date
14/02/2013
Compliance outcome
positive

Decision

How useful was this page?

Add your rating